米非司酮联合利凡诺在中期妊娠引产中的应用研究

潘爱丽, 范彬, 朱昌国

潘爱丽, 范彬, 朱昌国. 米非司酮联合利凡诺在中期妊娠引产中的应用研究[J]. 实用临床医药杂志, 2014, (7): 144-146. DOI: 10.7619/jcmp.201407051
引用本文: 潘爱丽, 范彬, 朱昌国. 米非司酮联合利凡诺在中期妊娠引产中的应用研究[J]. 实用临床医药杂志, 2014, (7): 144-146. DOI: 10.7619/jcmp.201407051
PAN Aili, FAN Bin, ZHU Changguo. Application of mifepristone combined with rivanol in midtrimester induction of labor[J]. Journal of Clinical Medicine in Practice, 2014, (7): 144-146. DOI: 10.7619/jcmp.201407051
Citation: PAN Aili, FAN Bin, ZHU Changguo. Application of mifepristone combined with rivanol in midtrimester induction of labor[J]. Journal of Clinical Medicine in Practice, 2014, (7): 144-146. DOI: 10.7619/jcmp.201407051

米非司酮联合利凡诺在中期妊娠引产中的应用研究

基金项目: 中国高校医学期刊临床专项资金
详细信息
  • 中图分类号: R719.3

Application of mifepristone combined with rivanol in midtrimester induction of labor

  • 摘要: 目的:探讨米非司酮联合利凡诺在中期妊娠引产中的临床疗效。方法需要引产的患者100例,随机分为实验组和对照组,各50例。对照组单纯给予利凡诺75 mg 羊膜腔内注射,实验组先给予利凡诺75 mg 羊膜腔内注射,同时空腹口服米非司酮75 mg,24 h 后再空腹口服75 mg。观察2组宫颈 Bishop 评分、宫缩发动时间、排胎时间、总产程、流产效果、产后出血量、副作用。结果用药后,实验组宫颈评分明显高于对照组;用药后,实验组宫缩发动时间、排胎时间、总产程较对照组明显减少。实验组引产有效率为100%,高于对照组引产有效率(92.0%),但2组比较差异无统计学意义。实验组产后出血量明显少于对照组。结论利凡诺联合米非司酮应用于中止中期妊娠,可更为有效地软化宫颈,缩短胎儿娩出时间,减少患者痛苦和相关并发症,改善产后恢复,是值得在临床上推广的引产方法。
    Abstract: Objective To explore the clinical efficacy of mifepristone combined with rivanol in induction of labor.Methods 100 patients requiring induction of labor were randomly divided in-to experimental group and control group with 50 patients in each group.The control group was giv-en intra-amniotic injection of 75 mg rivanol,while the patients in the experimental group orally took 75 mg mifepristone under fasting condition based on the therapy in the control group,and took another 75 mg after 24 hours.The score of cervical Bishop,onset time of uterus contraction,time to eliminate the fetus,total stage of labor,abortion effect,amount of postpartum hemorrhage and side effects were all observed in the two groups.Results After administration of the drugs,the score of cervical Bishop in the experimental group was markedly higher than that in the control group,while onset time of contraction,time to eliminate the fetus,total stage of labor and amount of postpartum hemorrhage were obviously less than that in the control group.The response rate of induction of labor in experimental group (1 0 0 % )was higher than that in the control group (92.0%),the difference was statistically significant.Conclusion Application of mifepristone com-bined with rivanol to terminate the pregnancy can effectively soften the cervix,shorten the time of delivery of baby,reduce patients′pain and relevant complications and ameliorate postpartum recov-ery,so it is worthy of clinically popularization.
  • 期刊类型引用(11)

    1. 黄珍,陶克奇,胡杏燕. 路径导向性健康教育对深静脉血栓形成介入术后患者的影响. 齐鲁护理杂志. 2024(06): 5-8 . 百度学术
    2. 刘茜巍,马琴,帕热旦木·托乎提. 基于前馈控制构建终末期肾病血液透析患者干预措施及其应用. 中国医药导报. 2024(07): 186-189 . 百度学术
    3. 李静,张品. 临床护理管理路径对肝病存在VTE风险患者自我护理能力的影响. 婚育与健康. 2024(07): 142-144 . 百度学术
    4. 吕晓兰,刘泽梅,章月照. 前馈控制护理策略预防肿瘤化疗深静脉置管患者相关并发症的效果. 中国医药导报. 2024(11): 152-155 . 百度学术
    5. 孔祥欣,蔡燕萍,郑国华. 基于综合转变模型的分阶段精细化护理干预慢性乙型肝炎患者的效果. 慢性病学杂志. 2024(06): 936-939 . 百度学术
    6. 陈芬芬,蒋赛珍,刘方艳. 预备控制护理联合积极共情反馈干预在玻璃体切除术联合视网膜激光光凝术患者中的应用效果. 医疗装备. 2024(10): 147-149+153 . 百度学术
    7. 丁雪丽,贾莉霞,李存存. 路径式前馈控制护理模式在重型肝炎患者中的应用价值. 国际医药卫生导报. 2024(14): 2437-2441 . 百度学术
    8. 许敏. 基于“治未病”健康护理模式在病毒性肝炎肝硬化中的应用. 承德医学院学报. 2024(05): 410-413 . 百度学术
    9. 傅金艳,胡蓉. 信息化监护联合前馈控制管理在老年白内障连台手术患者中的效果. 黑龙江中医药. 2024(03): 305-307 . 百度学术
    10. 李靓萍. 预先控制模式联合叙事干预在肝硬化失代偿期患者中的应用. 黑龙江医学. 2024(23): 2927-2929 . 百度学术
    11. 杨霞,万丽文. 前馈控制护理对超声引导下穿刺活检患者一次穿刺成功率及并发症的影响研究. 现代诊断与治疗. 2023(07): 1091-1093 . 百度学术

    其他类型引用(0)

计量
  • 文章访问数:  205
  • HTML全文浏览量:  58
  • PDF下载量:  0
  • 被引次数: 11
出版历程
  • 发布日期:  2014-07-14

目录

    /

    返回文章
    返回